HLA Class I: An unexpected role in integrin β4 signaling in endothelial cells

Human Immunology

Volumn 73, Issue 12, 2012, Pages 1239-1244

  Zhang, Xiaohai ^a   Reed, Elaine F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BETA4 INTEGRIN; GELATINASE A; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERSTITIAL COLLAGENASE; KALININ; PROTEIN KINASE B;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CELL ACTIVATION; CELL PROLIFERATION; CHRONIC GRAFT REJECTION; ENDOTHELIUM CELL; GRAFT FAILURE; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSPLANT VASCULOPATHY; TRANSPLANTATION; VASCULAR DISEASE;

ANTIBODIES; CELL PROLIFERATION; CELL SURVIVAL; DISEASE PROGRESSION; ENDOTHELIAL CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTEGRIN BETA4; NEOPLASMS; NEURONS; SIGNAL TRANSDUCTION;

EID: 84869096402     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.06.013     Document Type: Article

References (78)

1. Reed E.F., Demetris A.J., Hammond E., Itescu S., Kobashigawa J.A., Reinsmoen N.L., et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006, 25:153.
2. Singh N., Pirsch J., Samaniego M. Antibody-mediated rejection: treatment alternatives and outcomes. Transplant Rev (Orlando) 2009, 23:34.
3. Leffell M.S., Zachary A.A. Antiallograft antibodies: relevance, detection, and monitoring. Curr Opin Organ Transplant 2010, 15:2.
4. Clatworthy M.R., Espeli M., Torpey N., Smith K.G. The generation and maintenance of serum alloantibody. Curr Opin Immunol 2010, 22:669.
5. Zhang Q., Cecka J.M., Gjertson D.W., Ge P., Rose M.L., Patel J.K., et al. HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation 2011, 91:1153.
6. Uehara S., Chase C.M., Cornell L.D., Madsen J.C., Russell P.S., Colvin R.B. Chronic cardiac transplant arteriopathy in mice. relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant 2007, 7:57.
7. Hirohashi T., Uehara S., Chase C.M., DellaPelle P., Madsen J.C., Russell P.S., et al. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010, 10:510.
8. Hirohashi T., Chase C.M., DellaPelle P., Sebastian D., Alessandrini A., Madsen J.C., et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant 2012, 12:313.
9. Galvani S., Auge N., Calise D., Thiers J.C., Canivet C., Kamar N., et al. HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice. Am J Transplant 2009, 9:2607.
10. Zhang X., Reed E.F. Effect of Antibodies on Endothelium. Am J Transplant 2009, 9:2459.
11. Leffell M.S., Zachary A.A. Anti-allograft antibodies: some are harmful, some can be overcome, and some may be beneficial. Discov Med 2010, 9:478.
12. Colvin R.B. Pathology of chronic humoral rejection. Contrib Nephrol 2009, 162:75.
13. Stegall M.D., Gloor J.M. Deciphering antibody-mediated rejection: new insights into mechanisms and treatment. Curr Opin Organ Transplant 2010, 15:8.
14. Mehra M.R., Crespo-Leiro M.G., Dipchand A., Ensminger S.M., Hiemann N.E., Kobashigawa J.A., et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 2010, 29:717.
15. Mitchell R.N., Libby P. Vascular remodeling in transplant vasculopathy. Circ Res 2007, 100:967.
16. Hosenpud J.D., Morris T.E., Shipley G.D., Mauck K.A., Wagner C.R. Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response. Transplantation 1996, 61:939.
17. Bayliss J., Bailey M., Leet A., Stein A.N., Thomson N.M., McLean C.A. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Transplantation 2008, 86:991.
18. Aziz T., Hasleton P., Hann A.W., Yonan N., Deiraniya A., Hutchinson I.V. Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation. J Thorac Cardiovasc Surg 2000, 119:700.
19. Colvin R.B., Smith R.N. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005, 5:807.
20. Yamakuchi M., Kirkiles-Smith N.C., Ferlito M., Cameron S.J., Bao C., Fox-Talbot K., et al. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci U S A 2007, 104:1301.
21. Kitchens W.H., Chase C.M., Uehara S., Cornell L.D., Colvin R.B., Russell P.S., et al. Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 2007, 7:2675.
22. Li F., Zhang X., Jin Y.P., Mulder A., Reed E.F. Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner. Hum Immunol 2011, 72:1150.
23. Jin Y.P., Korin Y., Zhang X., Jindra P.T., Rozengurt E., Reed E.F. RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells. J Immunol 2007, 178:7911.
24. Ziegler M.E., Souda P., Jin Y.P., Whitelegge J.P., Reed E.F. Characterization of the endothelial cell cytoskeleton following HLA class I ligation. PLoS One 2012, 7:e29472.
25. Jindra P.T., Jin Y.P., Rozengurt E., Reed E.F. HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol 2008, 180:2357.
26. Jindra P.T., Jin Y.P., Jacamo R., Rozengurt E., Reed E.F. MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway. Biochem Biophys Res Commun 2008, 369:781.
27. Jindra P.T., Hsueh A., Hong L., Gjertson D., Shen X.D., Gao F., et al. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol 2008, 180:2214.
28. Miranti C.K., Brugge J.S. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 2002, 4:E83.
29. Abdel-Ghany M., Cheng H.-C., Elble R.C., Pauli B.U. Focal Adhesion Kinase Activated by beta 4 Integrin Ligation to mCLCA1 Mediates Early Metastatic Growth. J Biol Chem 2002, 277:34391.
30. Giancotti F.G. Targeting integrin beta4 for cancer and anti-angiogenic therapy. Trends Pharmacol Sci 2007, 28:506.
31. Zhang X., Rozengurt E., Reed E.F. HLA class I molecules partner with integrin beta4 to stimulate endothelial cell proliferation and migration. Sci Signal 2010, 3:85.
32. Sun C., Liu X., Qi L., Xu J., Zhao J., Zhang Y., et al. Modulation of vascular endothelial cell senescence by integrin beta4. J Cell Physiol 2010, 225:673.
33. Jindra P.T., Zhang X., Mulder A., Claas F., Veale J., Jin Y.P., et al. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 2006, 82:S33.
34. Salama A.D., Delikouras A., Pusey C.D., Cook H.T., Bhangal G., Lechler R.I., et al. Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. Am J Transplant 2001, 1:260.
35. Montgomery R.A., Lonze B.E., King K.E., Kraus E.S., Kucirka L.M., Locke J.E., et al. Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 2011, 365:318.
36. Hachem R.R., Yusen R.D., Meyers B.F., Aloush A.A., Mohanakumar T., Patterson G.A., et al. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant 2010, 29:973.
37. Jordan S.C., Kahwaji J., Toyoda M., Vo A. B-cell immunotherapeutics: emerging roles in solid organ transplantation. Curr Opin Organ Transplant 2011, 16:416.
38. Walsh R.C., Alloway R.R., Girnita A.L., Woodle E.S. Proteasome inhibitor-based therapy for antibody-mediated rejection. Kidney Int 2012, 81:1067.
39. Guthoff M., Schmid-Horch B., Weisel K.C., Haring H.U., Konigsrainer A., Heyne N. Proteasome inhibition by bortezomib: Effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation. Transpl Immunol 2012, 26:171.
40. Chevalier G., Suberbielle E., Monnet C., Duplan V., Martin-Blondel G., Farrugia F., et al. Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection. PLoS Pathog 2011, 7:e1002393.
41. Nikolopoulos S.N., Blaikie P., Yoshioka T., Guo W., Giancotti F.G. Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell 2004, 6:471.
42. Previtali S., Quattrini A., Nemni R., Truci G., Ducati A., Wrabetz L., et al. Alpha6 beta4 and alpha6 beta1 integrins in astrocytomas and other CNS tumors. J Neuropathol Exp Neurol 1996, 55:456.
43. Ni H., Dydensborg A.B., Herring F.E., Basora N., Gagne D., Vachon P.H., et al. Upregulation of a functional form of the beta4 integrin subunit in colorectal cancers correlates with c-Myc expression. Oncogene 2005, 24:6820.
44. Chao C., Lotz M.M., Clarke A.C., Mercurio A.M. A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells. Cancer Res 1996, 56:4811.
45. Robertson J.H., Yang S.Y., Winslet M.C., Seifalian A.M. Functional blocking of specific integrins inhibit colonic cancer migration. Clin Exp Metastasis 2009, 26:769.
46. Daemi N., Thomasset N., Lissitzky J.C., Dumortier J., Jacquier M.F., Pourreyron C., et al. Anti-beta4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP-2 expression. Int J Cancer 2000, 85:850.
47. Galvani S., Trayssac M., Auge N., Thiers J.C., Calise D., Krell H.W., et al. A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody. Circulation 2011, 124:2725.
48. Hariya A., Takazawa K., Yamamoto T., Amano A. ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant. J Heart Lung Transplant 2004, 23:1163.
49. Lu S., Simin K., Khan A., Mercurio A.M. Analysis of integrin beta4 expression in human breast cancer: association with basal-like tumors and prognostic significance. Clin Cancer Res 2008, 14:1050.
50. Boelens M.C., van den Berg A., Vogelzang I., Wesseling J., Postma D.S., Timens W., et al. Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus. J Clin Pathol 2007, 60:608.
51. Ueda Y., Ishikawa K., Shiraishi N., Yokoyama S., Kitano S. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer. J Surg Oncol 2008, 97:451.
52. Holmes K., Egan B., Swan N., O'Morain C. Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma. Curr Genomics 2007, 8:379.
53. Rakoff-Nahoum S. Why cancer and inflammation?. Yale J Biol Med 2006, 79:123.
54. Ferrone C., Dranoff G. Dual roles for immunity in gastrointestinal cancers. J Clin Oncol 2010, 28:4045.
55. Tsujimoto H., Ono S., Ichikura T., Matsumoto Y., Yamamoto J., Hase K. Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?. Gastric cancer 2010, 13:212.
56. Ramnath N., Tan D., Li Q., Hylander B.L., Bogner P., Ryes L., et al. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?. Cancer Immunol Immunother 2006, 55:891.
57. Madjd Z., Spendlove I., Pinder S.E., Ellis I.O., Durrant L.G. Total loss of MHC class I is an independent indicator of good prognosis in breast cancer. Int J Cancer 2005, 117:248.
58. Jaakkola S., Savunen O., Halme T., Uitto J., Peltonen J. Basement membranes during development of human nerve: Schwann cells and perineurial cells display marked changes in their expression profiles for laminin subunits and beta 1 and beta 4 integrins. J Neurocytol 1993, 22:215.
59. Su L., Zhao B., Lv X., Wang N., Zhao J., Zhang S., et al. Safrole oxide induces neuronal apoptosis through inhibition of integrin beta4/SOD activity and elevation of ROS/NADPH oxidase activity. Life Sci 2007, 80:999.
60. Milner R., Campbell I.L. Increased expression of the beta4 and alpha5 integrin subunits in cerebral blood vessels of transgenic mice chronically producing the pro-inflammatory cytokines IL-6 or IFN-alpha in the central nervous system. Mol Cell Neurosci 2006, 33:429.
61. Jacques T.S., Relvas J.B., Nishimura S., Pytela R., Edwards G.M., Streuli C.H., et al. Neural precursor cell chain migration and division are regulated through different beta1 integrins. Development 1998, 125:3167.
62. Zhang Z., Galileo D.S. Retroviral transfer of antisense integrin alpha6 or alpha8 sequences results in laminar redistribution or clonal cell death in developing brain. J Neurosci 1998, 18:3336928.
63. Whitley M., Treloar H., De Arcangelis A. Georges Labouesse E, Greer CA: The alpha6 integrin subunit in the developing mouse olfactory bulb. J Neurocytol 2005, 34:81.
64. Su L., Lv X., Miao J. Integrin beta 4 in neural cells. Neuromolecular Med 2008, 10:316.
65. Boulanger L.M., Shatz C.J. Immune signalling in neural development, synaptic plasticity and disease. Nat Rev Neurosci 2004, 5:521.
66. Fourgeaud L., Davenport C.M., Tyler C.M., Cheng T.T., Spencer M.B., Boulanger L.M. MHC class I modulates NMDA receptor function and AMPA receptor trafficking. Proc Natl Acad Sci U S A 2010, 107:22278.
67. Thams S., Oliveira A., Cullheim S. MHC class I expression and synaptic plasticity after nerve lesion. Brain Res Rev 2008, 57:265.
68. Zohar O., Reiter Y., Bennink J.R., Lev A., Cavallaro S. Paratore Set al.: Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. J Immunol 2008, 180:6447.
69. Oliveira A.L., Thams S., Lidman O., Piehl F., Hokfelt T., Karre K., et al. A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy. Proc Natl Acad Sci U S A 2004, 101:17843.
70. Sabha M., Emirandetti A., Cullheim S., De Oliveira A.L. MHC I expression and synaptic plasticity in different mice strains after axotomy. Synapse 2008, 62:137.
71. Van der Zee C.E., Kreft M., Beckers G., Kuipers A., Sonnenberg A. Conditional deletion of the Itgb4 integrin gene in Schwann cells leads to delayed peripheral nerve regeneration. J Neurosci 2008, 28:11292.
72. Fu Z.Q., Shao Q.L., Shen J.L., Zhang Y.J., Zhao X.X., Yao L. Effect of carbamylated erythropoietin on major histocompatibility complex expression and neural differentiation of human neural stem cells. J Neuroimmunol 2010, 221:15.
73. Su L., Lv X., Xu J., Yin D., Zhang H., Li Y., et al. Neural stem cell differentiation is mediated by integrin beta4 in vitro. Int J Biochem Cell Biol 2009, 41:916.
74. Johnson D.R. Locus-specific constitutive and cytokine-induced HLA class I gene expression. J Immunol 2003, 170:1894.
75. Balas A., Santos S., Aviles M.J., Garcia-Sanchez F., Lillo R., Alvarez A., et al. Elongation of the cytoplasmic domain, due to a point deletion at exon 7, results in an HLA-C null allele, Cw*0409 N. Tissue Antigens 2002, 59:95.
76. Jin Y.P., Zhang X.H., Mulder A., Claas F.H.J., Lee J.H., Reed E.F. not all class i molecules associate with integrin beta4 to transduce signals: mechanisms and clinical implications. Hum Immunol 2011, 72:S178.
77. Brendle A., Lei H., Brandt A., Johansson R., Enquist K., Henriksson R., et al. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis 2008, 29:1394.
78. Hirano A., Nagai H., Harada H., Terada Y., Haga S., Kajiwara T., et al. Nine novel single-nucleotide polymorphisms in the integrin beta4 (ITGB4) gene in the Japanese population. J Hum Genet 2001, 46:35.